The European Parliament has today called on the EU to work to improve access to PrEP (pre-exposure prophylaxis) as a means of preventing HIV infection.
In a vote on a resolution on the EU’s response to HIV/AIDS, Tuberculosis and Hepatitis C, MEPs backed a call to improve access to innovative treatments for HIV, such as PrEP; to combat the stigma attached to the disease; and to promote education and prevention.
PrEP, which is currently only available on the NHS in Scotland, sees people taking an antiretroviral drug in order to reach optimal levels of protection from infection. The European Parliament’s resolution acknowledged the strong evidence that the treatment ‘all but eliminates the risk of transmission where viral loads are reduced to undetectable levels.’ 
Seb Dance, Labour Member of the European Parliament for London, said;
"It is hugely encouraging to see the European Parliament taking a stand on this issue, and also accepting my contribution on the strong evidence of the effectiveness of PrEP. Improving access to this treatment across the EU will have a transformative effect on people’s lives.
“It is vital that we continue to invest in research to achieve effective cures for HIV, but also that we make sure that a treatment that has proven to be an incredibly successful means of prevention is accessible and affordable across the EU.
“HIV still carries with it a social stigma, and it is excellent that the European Parliament, as well as calling for better education and prevention programmes, has also committed again to combating the stigma attached to HIV infection.”
For further information, please contact Scott Dobson on 07727869640 or at email@example.com